Value of transesophageal cardiac electrophysiology in the diagnosis of paroxysmal supraventricular tachycardia

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2100053295

Enrollment

Unknown

Registered

2021-11-18

Start date

2022-01-01

Completion date

Unknown

Last updated

2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Paroxysmal supraventricular tachycardia

Interventions

Gold Standard:ECG showed paroxysmal supraventricular tachycardia.

Index test:Transesophageal&#32

cardiac&#32

electrophysiological&#32

examination.

Eligibility

Sex/Gender

All

Age

18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Patients with paroxysmal palpitation or paroxysmal supraventricular tachycardia on ECG.

Exclusion criteria

Exclusion criteria: 1. Patients with contraindications to transesophageal cardiac electrophysiological examination; 2. Patients with other serious diseases.

Design outcomes

Primary

Measure	Time frame
Diagnostic rate;	—

Secondary

Measure	Time frame
Missed diagnosis rate;	—

Countries

China

Contacts

Public ContactXiao Shaowu

Wenchang People's Hospital

250697901@qq.com+86 18689979508

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026